首页> 外国专利> A process for the manufacture of cardio-active materials from the glucosides of digitalis and scilla

A process for the manufacture of cardio-active materials from the glucosides of digitalis and scilla

机译:一种由洋地黄和绵的葡萄糖苷制造心脏活性物质的方法

摘要

The glucosides of Digitalis and Scilla or mixtures thereof are treated with enzymes present in Digitalis and Scilla, whereby they are hydrolysed, and cardioactive glucosides not containing a glucose residue are obtained. The glucosides may be treated before, during or after their extraction from the fresh or dried drug, and the treatment may be effected in water or in an aqueous solution of an organic solvent, or--when starting from the fresh drug--in the presence of a compound capable of killing the cells and arresting putrefaction, e.g. ethyl acetate, chloroform, toluene, methanol or ethanol. Glucoside A of Digitalis lanata (cf. Specification 370,344) is converted by the process into a new glucoside which yields on acid hydrolysis an aglucone (digitoxigenin), digitoxose, and acetic acid; if the new glucoside is disacetylated with dilute alkali solution, digitoxin is obtained. Glucoside B of Digitalis lanata is converted into a new glucoside which yields on acid hydrolysis an aglucone (gitoxigenin), digitoxose, and acetic acid; if the new glucoside is disacetylated, gitoxin is obtained. Glucoside C of Digitalis lanata is converted into a new glucoside which yields on acid hydrolysis an aglucone (digoxigenin), digitoxose, and acetic acid; if the new glucoside is disacetylated, digoxin is obtained. The disacetylated glucosides A, B, and C of Digitalis lanata (cf. Specification 406,197) are similarly converted into nonglucosic glucosides. The Scilla glucoside scillaren A is converted into a new glucoside, called proscillaridin A, which yields on acid hydrolysis an aglucone (scillaridin A) and rhamnose. In the examples: (1) comminuted fresh bulbs of Scilla maritima are allowed to stand in ethyl acetate for five days, during which time the enzyme present (scillarenase) converts the scillaren A into proscillaridin A, which is then isolated by a series of operations described in detail; (2) an enzyme preparation is obtained from comminuted bulbs of Scilla maritima by immersing them in water saturated with thymol, allowing the mixture to stand for 14 days, and filtering the product successively through cloth and a talc filter; the portion retained by the talc filter contains the enzyme; scillaren A is treated with this preparation in a mixture of water, toluene and acetic acid, and after 20 hours the mixture is filtered and proscillaridin A isolated from the filter residue by an extraction process; (3) comminuted leaves of Digitalis purpurea are allowed to stand in ethyl acetate for 3--4 days, whereby the glucosides are coverted into digitoxin, the isolation of which from the product is described; (4) dried leaves of Digitalis lanata are treated as in example 3 to produce a mixture of nonglucosic glucosides; (5) the disacetylated glucoside A of Digitalis lanata is treated for 2--3 days in ethanol solution with comminuted leaves of Digitalis purpurea; a nonglucosic glucoside resembling digitoxin is obtained. Specification 357,926 also is referred to.
机译:用洋地黄和Scilla中存在的酶处理洋地黄和Scilla的葡糖苷或其混合物,从而使它们水解,从而获得不含葡萄糖残基的心脏活性葡糖苷。可以在从新鲜或干燥药物中提取糖苷之前,之中或之后进行处理,并且可以在水或有机溶剂的水溶液中进行处理,或者-从新鲜药物开始时-在能够杀死细胞并阻止腐败的化合物的存在,例如乙酸乙酯,氯仿,甲苯,甲醇或乙醇。通过该方法将洋地黄的葡糖苷A(参见规格370,344)转化为新的葡糖苷,其在酸水解后产生葡糖苷(洋地黄毒苷),洋地黄糖和乙酸;如果新的葡萄糖苷用稀碱溶液脱乙酰,则会得到洋地黄毒苷。洋地黄的葡糖苷B被转化为新的葡糖苷,其在酸水解时产生了葡糖苷(gitoxigenin),洋地黄糖和乙酸。如果新的葡糖苷被脱乙酰,则获得了胃毒素。洋地黄的葡糖苷C被转化为新的葡糖苷,其在酸水解时产生葡糖苷(洋地黄毒苷),洋地黄糖和乙酸。如果新的葡糖苷被脱乙酰,则会获得地高辛。洋地黄的脱乙酰基葡糖苷A,B和C(参见规格406,197)类似地转化为非葡糖苷。 Scilla葡糖苷scillaren A被转化为新的葡糖苷,称为proscillaridin A,它在酸水解后产生一个苷元(scillaridin A)和鼠李糖。在示例中:(1)将切碎的新鲜海绵球茎在乙酸乙酯中放置5天,在此期间,存在的酶(海鞘酶)将海鞘A转化为海鞘磷脂A,然后通过一系列操作将其分离详细描述; (2)将海藻的粉碎后的球茎浸入百里酚饱和的水中,静置14天,并依次用布和滑石粉过滤,得到酶制剂。滑石过滤器保留的部分含有酶;用该制剂在水,甲苯和乙酸的混合物中处理鞘脂A,并在20小时后过滤混合物,并通过萃取工艺从滤渣中分离出螺旋藻苷A; (3)将洋地黄的切碎的叶子在乙酸乙酯中放置3-4天,由此将葡糖苷覆盖在洋地黄毒苷中,描述了从产物中的分离。 (4)按实施例3处理洋地黄的干叶,以产生非葡萄糖苷的混合物。 (5)将洋地黄的脱乙酰基葡糖苷A在乙醇溶液中用洋地黄粉碎后的叶子处理2-3天。获得类似于洋地黄毒苷的非葡萄糖苷。也参考规格357,926。

著录项

  • 公开/公告号GB405890A

    专利类型

  • 公开/公告日1934-02-15

    原文格式PDF

  • 申请/专利权人 CHEMICAL WORKS;

    申请/专利号GB19330020811

  • 发明设计人

    申请日1933-07-24

  • 分类号C07G3/00;

  • 国家 GB

  • 入库时间 2022-08-24 06:57:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号